These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20632974)

  • 1. New frontiers in G protein-coupled receptor regulation of neurological disorders.
    Maudsley S
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):525. PubMed ID: 20632974
    [No Abstract]   [Full Text] [Related]  

  • 2. GABAB receptors-associated proteins: potential drug targets in neurological disorders?
    Lujan R; Ciruela F
    Curr Drug Targets; 2012 Jan; 13(1):129-44. PubMed ID: 22023408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia--a therapeutic target in neurological diseases and disorders.
    Kaur C; Ling EA
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):719. PubMed ID: 24047518
    [No Abstract]   [Full Text] [Related]  

  • 4. TGR5 as a therapeutic target for treating obesity.
    Zhong M
    Curr Top Med Chem; 2010; 10(4):386-96. PubMed ID: 20180762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deorphanisation of G protein-coupled receptors: A tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs.
    Lecca D; Abbracchio MP
    Neurochem Int; 2008 Feb; 52(3):339-51. PubMed ID: 17884255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
    Tiwari A; Maiti P
    Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting kinin receptors for the treatment of neurological diseases.
    Rodi D; Couture R; Ongali B; Simonato M
    Curr Pharm Des; 2005; 11(10):1313-26. PubMed ID: 15853687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Current Strategies for Drug Discovery Targeting Neurological Autoimmune Diseases.
    Skundric DS
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):3. PubMed ID: 29474167
    [No Abstract]   [Full Text] [Related]  

  • 11. Different targets of anti-glucocorticoid treatment have been proposed, acting at supra-hypothalamic, HPA axis, glucocorticoid receptor and post-receptor levels.
    Di Marzo V
    Recent Pat CNS Drug Discov; 2013 Apr; 8(1):1. PubMed ID: 23565885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
    Soni N; Reddy BV; Kumar P
    Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide drugs to target G protein-coupled receptors.
    Bellmann-Sickert K; Beck-Sickinger AG
    Trends Pharmacol Sci; 2010 Sep; 31(9):434-41. PubMed ID: 20655603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Drug Treatment Paradigms for Metabolic and Neurological Disorders.
    Sivanesan S
    Curr Pharm Des; 2019; 25(33):3499. PubMed ID: 31774043
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNAs as CNS Drug Targets.
    Gurwitz D
    Drug Dev Res; 2016 Nov; 77(7):331-335. PubMed ID: 27569840
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting epigenetics in nervous system disease.
    Zhang R; Lu J; Kong X; Jin L; Luo C
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):126-41. PubMed ID: 23244434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho kinase, a promising drug target for neurological disorders.
    Mueller BK; Mack H; Teusch N
    Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of multivalent ligand targeting G-protein-coupled receptors.
    Liu Z; Zhang J; Zhang A
    Curr Pharm Des; 2009; 15(6):682-718. PubMed ID: 19199990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.